Every healthcare merger tells two stories. The first is the one in the press release filled with promises of innovation and better care. The second takes place in the data room, where teams race to find out whether a target’s digital systems are strong enough to survive integration.
That second story decides whether the deal succeeds or fails.
As hospital systems, biotech firms, and insurers merge, data privacy has become the quiet risk that can topple everything. Patient records are no longer simple medical charts. They are valuable, vulnerable, and, in the wrong context, dangerous.
Due diligence once meant reviewing billing and compliance records. Now it means tracing the flow of patient data through cloud servers, third-party vendors, and legacy systems. Buyers are not only asking how much a company earns but whether it can legally keep the information that drives those earnings.
The New Legal Battlefield
HIPAA and HITECH still form the backbone of healthcare privacy law, but they are no longer enough. Regulators now look for cultural negligence as much as technical failure. Companies are fined not just for breaches, but for failing to prevent them.
A merger compounds those risks. Once two organizations connect systems, one weak link can compromise millions of patient records. When a breach occurs, regulators rarely care who caused it. The buyer inherits the responsibility.
Healthcare transactions now require deeper audits into how data is stored, encrypted, and shared. The companies that fail to ask hard questions before closing often spend years untangling the results.
Why the Fine Print Matters
Representations and warranties used to be formalities. Today, they are survival tools. They define whether a seller has followed federal and state laws, reported all known breaches, and maintained a functioning privacy program.
But these clauses can also miss the reality of modern healthcare. Data is scattered across devices, cloud networks, and research partnerships. If diligence teams only look at official systems, they may miss the shadow networks where risk lives.
A breach discovered after closing can erase years of profit. It can also bring lawsuits from patients and regulators who view the new owner as the responsible party.
A New Kind of Due Diligence
The complexity of modern deals has created demand for lawyers who understand both law and technology. Among them is Steven Okoye, an attorney who built his career around the intersection of data and healthcare.
Okoye graduated from Rutgers Law School in 2017, where he served as Managing Technology Editor of the Rutgers Journal of Law and Public Policy. He received the Judge William H. Hyatt Jr. Scholarship for academic performance and leadership, as his research focused on digital compliance in healthcare. He also coached younger law students while driving from Pennsylvania to New Jersey and taking care of his wife, who was a medical resident in New York City.
Recognized as an Outstanding Law School Graduate, Okoye now advises on healthcare transactions in New York. His work reflects a view that data privacy is not a technical checklist but a measure of corporate honesty. If an organization cannot show records of security testing, breach drills, or vendor reviews, it is not prepared for acquisition.
The Indemnification Trap
Even when buyers uncover weaknesses, contract language often fails them later. Indemnification clauses can appear solid until a breach occurs. Then the dispute shifts to timing and knowledge. Was the problem known before the sale? Should it have been discovered during diligence?
In healthcare, the difference can mean millions in penalties. Cyber insurance rarely fills the gap. Modern policies restrict coverage and exclude incidents linked to poor diligence. Buyers who assume insurance will rescue them often learn too late that it will not.
The Culture Problem
The most dangerous vulnerabilities are not in code but in culture. A company that views privacy as an inconvenience cannot change overnight. When systems merge, that attitude spreads. It shapes how employees store data, respond to threats, and report them quickly.
Lawyers like Okoye emphasize that diligence is as much psychological as technical. It reveals whether leadership treats privacy as a daily habit or a compliance box to tick. The answer predicts how that company will behave when a crisis hits.
When Compliance Becomes Strategy
In the past, privacy was seen as an expense. Now it is a form of value. A company that can prove secure handling of patient data gains leverage with investors, lenders, and regulators. Privacy discipline speeds approvals and strengthens valuations.
Buyers are beginning to see privacy not as legal red tape but as a signal of organizational health. A clean privacy record shows that the company has good management, strong leadership, and can be counted on to do what it says it will do following the deal.
This is a great place for professionals like Steven Okoye to work. They help legal teams and technologists communicate and link compliance to business results. They do more than just lower risks. It’s about ensuring digital integrity is built into the contract from the start.
The New Normal
The online transformation of healthcare is speeding up. Artificial intelligence, remote diagnostics, and genetic data are changing the meaning of privacy. Every new idea opens up new possibilities, but it also brings with it new risks.
After the deal is done, privacy will need to be monitored continuously for future M&A deals. Buyers will need to prove that they not just looked at the systems once, but that they keep checking them.
Data privacy due diligence is now the moral compass for healthcare acquisitions. It makes businesses think about what they are really buying. A good privacy foundation makes people trust you. A weak one can ruin it.
In a world where patient data is both the lifeblood and the risk of healthcare, due diligence is no longer a line item. The story will decide whether the merger lasts.

If your colleague, friend, or family member is making an impact in their career, industry, or community, we want to hear about it.